Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors

Published:2019-07 Issue: Volume:173 Page:185-202
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cheng Chunhui,Yun Fan,He Jie,Ullah Sadeeq,Yuan Qipeng

Funder

National Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference43 articles.

1. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer;Johnstone;Nat. Rev. Drug Discov.,2002

2. Histone deacetylases and cancer;Glozak;Oncogene,2007

3. Acetylation and deacetylation of non-histone proteins;Glozak;Gene,2005

4. The structure and function of histone deacetylases: the target for anti-cancer therapy;Yingjie;Curr. Med. Chem.,2008

5. Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin;PA;Hum. Mol. Genet.,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases;Journal of Medicinal Chemistry;2024-09-10

2. Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years;ChemMedChem;2024-08-29

3. Design, Synthesis, and Biological Evaluation of New Urushiol Derivatives as Potent Class I Histone Deacetylase Inhibitors;ChemBioChem;2023-08-11

4. Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-one-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity;International Journal of Molecular Sciences;2023-07-03

5. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12